In spite of this, the JNK inhibiting effects of D-JNKI1 have been assessed in various disease contexts including cancer, where it has been shown to suppress the growth of xenografted HCC cells and chemically induced liver cancers [55], and attenuate tumor growth and cancer pain development in murine melanoma models [56]. This evidence concerns the gene MAPK8 and cancer.